Vivro Financial Services Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement for the attention of the Equity Shareholders of Shree Pacetronix Ltd ("Target ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivro Financial Services, the manager to the offer, has filed the Detailed Public Statement for a mandatory open offer to acquire up to 9,75,000 equity shares (26% of expanded share capital) of Shree Pacetronix Limited at ₹100 per share, totaling ₹9.75 crore. The offer is triggered by a Securities Subscription Agreement (SSA) dated August 7, 2025, under which the company will issue 75,150 equity shares and 2,25,450 convertible warrants to Akash Sethi (Joint Managing Director) at ₹81 per share, aggregating ₹2.43 crore. Akash Sethi (son) is the acquirer, with his father Atul Kumar Sethi (Managing Director), mother Amita Sethi, and brother Ashish Sethi as PACs — all current promoters. Post-offer, the promoter group holding will rise from 24.25% to 55.09% on a fully diluted basis. Shree Pacetronix manufactures implantable pacemakers, pacing leads, and pacing system analyzers, listed on BSE (scrip 527005). The tendering period is scheduled from October 3 to October 16, 2025.
Existing public shareholders can tender their shares at ₹100 per share — a slight premium over the 60-day volume-weighted average of ₹99.95. The offer signals promoter family consolidation and increased control, with no delisting planned. No major change in business operations is proposed.